# Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling.

> **Open Intelligence Dossier** · First detected: 2026-08-08 05:07 UTC · Category: Business

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-08/replimune-wins-fda-skin-cancer-drug-approval-on-third-try-why-the-stock-is*